Recent Updates
Recently added Catalysts
GRAL Positive Sentiment Score: 75/100

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company...

Monday, November 4, 2024 1 min read
Key Takeaway: GRAIL, Inc. has announced that its management will be presenting at the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum in New York on November 21. This event aims to highlight innovations in early cancer detection, aligning with GRAIL's mission. In addition, live webcasts of the presentation will be accessible through the company's investor relations website, with an archive available for at least 30 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • GRAIL is focused on early cancer detection, which is crucial for improving patient outcomes.
  • The presentation at a reputable forum suggests strong industry recognition and possible investor interest.

Full Press Release Details

MENLO PARK, Calif. , Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL ), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET .
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com . The webcast will be archived and available for reply for at least 30 days after the event.
SOURCE GRAIL, Inc.

21 %

Frequently Asked Questions

When will GRAIL present at the forum?

GRAIL will present on November 21, 2024, at 11:00 a.m. ET.

Where can I access the live webcast?

The live webcast can be accessed in the investor relations section of GRAIL's website.

Will the webcast be available after the event?

Yes, the webcast will be archived for at least 30 days.

What is GRAIL's mission?

GRAIL's mission is to detect cancer early when it can be cured.

Tags: GRAL Viatris Investor Conferences Healthcare GRAIL cancer detection MedTech Diagnostics healthcare
Last updated: Nov 4, 2024